家庭上肠道营养和晚期癌症的存活率:回顾性队列研究
Mei-Ti Wang1, Shao-Ming Yu2,3, Yi-Ping Pan4
1Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
BMJ supportive & palliative care
|January 13, 2026
概括
家庭亲肠道营养 (HPN) 可能会延长晚期癌症的台湾患者的生存期. 识别受益人的关键因素包括绩效状态,营养标志物和做不复苏 (DNR) 状态.
科学领域:
- 在瘤学瘤学.
- 临床营养学 临床营养学
背景情况:
- 家庭亲肠道营养 (HPN) 显示出改善晚期癌症患者的生存率和生活质量的潜力.
- 确定适合HPN的候选人对于优化息护理环境的结果至关重要.
研究的目的:
- 追溯分析与接受HPN的台湾晚期癌症患者的生存相关的临床特征.
- 为了比较接受HPN和仅接受息治疗的患者之间的生存结果.
主要方法:
- 对410名台湾癌症晚期患者 (≥3个先前治疗线) 的回顾性分析.
- 将HPN组与单独的息治疗组进行比较,根据性别,癌症类型和治疗史进行匹配.
- 使用生存分析分析的人口,临床,营养,炎症,性能状态 (PS) 和做不复苏 (DNR) 数据的分析.
主要成果:
- 在HPN组中,平均存活时间显著较长 (77天与17天相比,p<0.001).
- 接受HPN治疗的患者年轻,表现更好 (ECOG PS ≤2),DNR同意者较少,并且更有可能接受持续的癌症治疗.
- 低绩效状态 (ECOG PS>2),DNR同意和修改后的格拉斯哥预后得分为2独立地与更短的存活期相关;HPN使用与死亡风险降低相关.
结论:
- 在选择的台湾癌症晚期患者中,HPN可能会延长生存期.
- 性能状态,营养和炎症标志物以及DNR状态是HPN益处的关键预测因素.
- 进一步的研究应侧重于完善高级癌症护理中对HPN的患者选择标准.
相关概念视频
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
814
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
814
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
743
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
743
Enteral Nutrition I: Orogastric and Nasogastric Feeding
1.2K
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.2K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143

